reviewThe Lancet Infectious DiseasesJul 5, 2022GREEN OA

Monoclonal antibody therapies against SARS-CoV-2

DFDaniele FocosiSAScott A. McConnellACArturo CasadevallECEmiliano CappelloGVGiulia Valdiserra

Johns Hopkins University · University of Pisa

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

278
total citations
FWCI
26.42
Percentile
100%
References
213
Citations per year

Authors

6

Topics & keywords

Topics
Keywords
  • Monoclonal antibody
  • Pandemic
  • Coronavirus disease 2019 (COVID-19)
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
  • Virology
  • 2019-20 coronavirus outbreak
  • Medicine
  • Authorization
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.